Tudor Investment Corp’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.17M Sell
57,750
-17,316
-23% -$952K 0.01% 719
2025
Q1
$5.31M Sell
75,066
-24,659
-25% -$1.74M 0.02% 461
2024
Q4
$6.55M Buy
99,725
+6,957
+7% +$457K 0.02% 357
2024
Q3
$6.52M Buy
+92,768
New +$6.52M 0.02% 374
2023
Q1
Sell
-39,076
Closed -$4.04M 1575
2022
Q4
$4.04M Buy
+39,076
New +$4.04M 0.08% 288
2022
Q2
Sell
-7,976
Closed -$615K 1584
2022
Q1
$615K Buy
+7,976
New +$615K 0.01% 1029
2021
Q3
Sell
-2,814
Closed -$235K 1562
2021
Q2
$235K Buy
+2,814
New +$235K ﹤0.01% 1349
2021
Q1
Sell
-17,187
Closed -$1.51M 1529
2020
Q4
$1.51M Buy
17,187
+13,368
+350% +$1.17M 0.04% 531
2020
Q3
$291K Buy
+3,819
New +$291K 0.01% 987
2020
Q1
Sell
-8,036
Closed -$679K 1061
2019
Q4
$679K Sell
8,036
-28,771
-78% -$2.43M 0.03% 624
2019
Q3
$2.48M Buy
36,807
+5,754
+19% +$388K 0.09% 252
2019
Q2
$2.66M Buy
31,053
+245
+0.8% +$21K 0.08% 234
2019
Q1
$2.74M Buy
30,808
+5,290
+21% +$470K 0.11% 189
2018
Q4
$2.17M Sell
25,518
-8,939
-26% -$761K 0.04% 165
2018
Q3
$3.34M Buy
34,457
+16,795
+95% +$1.63M 0.08% 151
2018
Q2
$1.66M Buy
+17,662
New +$1.66M 0.06% 284
2018
Q1
Sell
-10,373
Closed -$925K 994
2017
Q4
$925K Sell
10,373
-9,392
-48% -$838K 0.02% 372
2017
Q3
$1.84M Buy
19,765
+3,498
+22% +$326K 0.05% 223
2017
Q2
$1.48M Buy
+16,267
New +$1.48M 0.05% 237
2015
Q4
Sell
-6,208
Closed -$654K 1492
2015
Q3
$654K Buy
6,208
+4,146
+201% +$437K 0.02% 558
2015
Q2
$282K Buy
+2,062
New +$282K 0.01% 1095
2014
Q4
Sell
-5,913
Closed -$427K 1437
2014
Q3
$427K Buy
+5,913
New +$427K 0.02% 758